Company: RPTX
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001193125-25-283336
Chunk: 1

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 1
---
 2024; 42,985,755 and 42,510,708 shares   issued and outstanding as of September 30, 2025 and December 31, 2024, respectively

     490,487

     486,674

     Warrants

     60

     10

     Additional paid-in capital

     85,893

     82,191

     Accumulated other comprehensive income

     14

     54

     Accumulated deficit

     (461,327
     )

     (417,798
     )

     Total shareholders’ equity

     115,127

     151,131

     TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
      
     $
     126,747

     $
     176,506

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements